NCT07591649
- Conditions
- Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- Mark Juckett, MD Minneapolis, Minnesota, United States
Clinical trial condition
Relapsed Adult AML
Explore clinical trials studying Relapsed Adult AML. Study availability and eligibility vary by location and protocol.
13 public trials
8 recruiting studies
Relapsed Adult AML trial results
Recruiting
Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19
NCT06649227
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- CHU de Lille Lille, France
NCT06307054
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
NCT05305859
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Bing Xu Xiamen, Fujian, China
NCT03850574
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
- Locations
-
- The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Irvine Irvine, California, United States
- UCSD Moores Cancer Center La Jolla, California, United States
Recruiting
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
NCT05237258
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Acute Myeloid Leukemia, +7 more
- Locations
-
- University of Alabama - Birmingham Birmingham, Alabama, United States
- Stanford University Stanford, California, United States
- University of Colorado Denver I Anschutz Medical Campus Denver, Colorado, United States
- University of Miami Miami, Florida, United States
NCT06022003
- Conditions
- AML, Adult, FLT3-ITD, FLT3-TKD Mutation, +9 more
- Locations
-
- Amiens CHU Amiens, France
- Angers CHU Angers, France
- Hôpital d'Instruction des Armées PERCY Clamart, France
- CHU Estaing Clermont-Ferrand, France
NCT06613217
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
- Locations
-
- MD Anderson Cancer Centre Houston, Texas, United States
Not Yet Recruiting
Menin-Inhibitor Targeted Maintenance in AML
NCT07563010
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
Not specified
NCT04139434
- Conditions
- AML/MDS, CMML, Disease Attributes, +20 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
- MD Anderson Cancer Center Huston, Texas, United States